You are here: Industry Insights > mRNA

News List

Africa Expands Vaccine Manufacturing Capacity Shem Oirere
March 08, 2022
The outbreak of COVID-19 pandemic has revived the drive by governments in Africa to expand local pharmaceutical manufacturing so as to increase access to affordable quality medicines for the continent’s 1.3 billion people.
Supported by Capital, the Application of mRNA Technology has Become a Hot Field in China PharmaSources/Xiaoyaowan
December 17, 2021
In the middle of August, Abogen Biosciences announced that it had completed a third round of financing with its total amount exceeding 700 million US dollars, which set a new record for single financing before IPO of Chinese biopharmaceutical companies.
AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials, AI-Enabled mRNA Major Vaccine Product Development Accelerates PR Newswire
March 24, 2025
AIM Vaccine's mRNA shingles vaccine got FDA clinical trial approval. Its platform has advantages, AI empowers it, and the vaccine market has great potential.
AIM Vaccine's mRNA Shingles Vaccine Submits Clinical Application to the U.S. PR Newswire
February 25, 2025
Another Step Forward in Global Expansion
Dx&Vx, From mRNA Vaccines to Nanoparticle Vaccines era of Next-Generation Vaccines PRNewswire
January 08, 2025
The COVID-19 pandemic has fundamentally transformed global healthcare systems and vaccine technologies.
Third mRNA Vaccine Dose Ups Effectiveness Against Hospitalization drugs.com
January 27, 2022
Receipt of a third COVID-19 mRNA vaccine dose is associated with increased vaccine effectiveness against COVID-19 hospitalization...
Moderna and Carisma collaborate to develop in-vivo engineered CAR-M for oncology ExpressPharma
January 11, 2022
The companies have partnered to discover, develop and commercialise in-vivo engineered Chimeric Antigen Receptor Monocyte (CAR-M) therapeutics for the treatment of cancer.
China rushes to develop an mRNA vaccine as doubts grow over local jabs FirstWordPharma
January 07, 2022
China's race to develop its own mRNA vaccine against COVID-19 has gained greater urgency as Beijing struggles to rein in an outbreak of the Omicron coronavirus variant that is threatening its "zero-Covid" policy, reported the Financial Times.
Moderna Announces Supply Agreement with South Korea for Additional 20 Million Doses of Moderna’s COVID-19 Vaccine or Updated Booster Candidate in 2022 FirstWordPharma
December 28, 2021
Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a revised supply agreement with the government of South Korea for 20 million doses...
Curia Launches Comprehensive mRNA Offering contractpharma
December 22, 2021
mRNA services combine experience and capabilities from discovery through fill-finish manufacturing.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page